chr4-39214601-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_025132.4(WDR19):​c.891C>T​(p.Cys297Cys) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.293 in 1,509,908 control chromosomes in the GnomAD database, including 66,124 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 6791 hom., cov: 31)
Exomes 𝑓: 0.29 ( 59333 hom. )

Consequence

WDR19
NM_025132.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.0005476
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 1.52
Variant links:
Genes affected
WDR19 (HGNC:18340): (WD repeat domain 19) The protein encoded by this gene is a member of the WD (tryptophan-aspartic acid) repeat family, which is a large family of structurally-related proteins known to participate in a wide range of cellular processes. Each WD repeat typically contains about 40 amino acids that are usually bracketed by glycine-histidine and tryptophan-aspartic acid (WD) dipeptides. This protein contains six WD repeats, three transmembrane domains, and a clathrin heavy-chain repeat. Mutations in this gene have been described in individuals with a wide range of disorders affecting function of the cilium. These disorders are known as ciliopathies, and include Jeune syndrome, Sensenbrenner syndromes, Senior-Loken syndrome, combined or isolated nephronophthisis (NPHP), and retinitis pigmentosa (RP). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 4-39214601-C-T is Benign according to our data. Variant chr4-39214601-C-T is described in ClinVar as [Benign]. Clinvar id is 261867.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-39214601-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=1.52 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.308 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDR19NM_025132.4 linkc.891C>T p.Cys297Cys splice_region_variant, synonymous_variant Exon 10 of 37 ENST00000399820.8 NP_079408.3 Q8NEZ3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDR19ENST00000399820.8 linkc.891C>T p.Cys297Cys splice_region_variant, synonymous_variant Exon 10 of 37 1 NM_025132.4 ENSP00000382717.3 Q8NEZ3-1

Frequencies

GnomAD3 genomes
AF:
0.298
AC:
45187
AN:
151540
Hom.:
6783
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.301
Gnomad AMI
AF:
0.397
Gnomad AMR
AF:
0.271
Gnomad ASJ
AF:
0.303
Gnomad EAS
AF:
0.168
Gnomad SAS
AF:
0.282
Gnomad FIN
AF:
0.299
Gnomad MID
AF:
0.291
Gnomad NFE
AF:
0.312
Gnomad OTH
AF:
0.305
GnomAD3 exomes
AF:
0.286
AC:
64441
AN:
225264
Hom.:
9463
AF XY:
0.289
AC XY:
35318
AN XY:
122298
show subpopulations
Gnomad AFR exome
AF:
0.293
Gnomad AMR exome
AF:
0.236
Gnomad ASJ exome
AF:
0.293
Gnomad EAS exome
AF:
0.157
Gnomad SAS exome
AF:
0.298
Gnomad FIN exome
AF:
0.298
Gnomad NFE exome
AF:
0.312
Gnomad OTH exome
AF:
0.285
GnomAD4 exome
AF:
0.292
AC:
396569
AN:
1358250
Hom.:
59333
Cov.:
24
AF XY:
0.293
AC XY:
198605
AN XY:
677786
show subpopulations
Gnomad4 AFR exome
AF:
0.283
Gnomad4 AMR exome
AF:
0.245
Gnomad4 ASJ exome
AF:
0.292
Gnomad4 EAS exome
AF:
0.175
Gnomad4 SAS exome
AF:
0.296
Gnomad4 FIN exome
AF:
0.296
Gnomad4 NFE exome
AF:
0.298
Gnomad4 OTH exome
AF:
0.292
GnomAD4 genome
AF:
0.298
AC:
45211
AN:
151658
Hom.:
6791
Cov.:
31
AF XY:
0.294
AC XY:
21781
AN XY:
74070
show subpopulations
Gnomad4 AFR
AF:
0.301
Gnomad4 AMR
AF:
0.271
Gnomad4 ASJ
AF:
0.303
Gnomad4 EAS
AF:
0.168
Gnomad4 SAS
AF:
0.283
Gnomad4 FIN
AF:
0.299
Gnomad4 NFE
AF:
0.312
Gnomad4 OTH
AF:
0.300
Alfa
AF:
0.306
Hom.:
11569
Bravo
AF:
0.298
Asia WGS
AF:
0.218
AC:
757
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Asphyxiating thoracic dystrophy 5 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jun 23, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Cranioectodermal dysplasia 4 Benign:2
Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nephronophthisis 13 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Senior-Loken syndrome 8 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Asphyxiating thoracic dystrophy 5;C4225376:Senior-Loken syndrome 8 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
13
DANN
Benign
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00055
dbscSNV1_RF
Benign
0.022
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2167494; hg19: chr4-39216221; COSMIC: COSV56464666; COSMIC: COSV56464666; API